Literature DB >> 3803137

Neural pathways for the release of gastrin, cholecystokinin, and pancreatic polypeptide after a meal in dogs. Role of gastric and splanchnic nerves.

C D Johnson, J A Chayvialle, M A Devaux, H Sarles.   

Abstract

We have measured gastrin, cholecystokinin (CCK), and pancreatic polypeptide (PP) release after a meal in normal dogs under basal conditions and during atropine infusion, and after various neural sections. Denervation of the gastric antrum (antral vagotomy) abolished the early part of the gastrin response to food. Truncal vagotomy, celiac ganglionectomy, and atropine reduced the early release of CCK, which occurred before the start of gastric emptying, suggesting that a neural, cholinergic mechanism may release CCK immediately after a meal. PP release was abolished by truncal vagotomy, and also by antral vagotomy. As no direct pathways are known between the antrum and the pancreas, this suggests either that antral afferents are essential for this response or that vagally mediated hormone release from the antrum mediates PP release.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803137     DOI: 10.1007/bf01299815

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  The neural control of exocrine and endocrine pancreas.

Authors:  O M Tiscornia
Journal:  Am J Gastroenterol       Date:  1977-06       Impact factor: 10.864

2.  Effect of atropine on pancreatic responses endogenous and exogenous cholecystokinin.

Authors:  S J Konturek; J Tasler; W Obtulowicz
Journal:  Am J Dig Dis       Date:  1972-10

3.  Release of cholecystokinin in response to food and intraduodenal fat in pigs, dogs and man.

Authors:  P Lilja; I Wiener; K Inoue; G M Fried; G H Greeley; J C Thompson
Journal:  Surg Gynecol Obstet       Date:  1984-12

4.  [Experimental odditis in dogs caused by chronic irritation of the right splanchnic nerve. Manometric, radiologic and anatomic study].

Authors:  J Lamy; H Sarles; G Michotey; H Richelme; H Payan; G Gastaud; J C Sarles
Journal:  Rev Fr Etud Clin Biol       Date:  1966 Jun-Jul

5.  Effect of extragastric vagotomy on pancreatic polypeptide in dogs.

Authors:  M Jonung; T Jonung; M H Chen; R F Murphy; S N Joffe
Journal:  Digestion       Date:  1984       Impact factor: 3.216

6.  Effect of atropine and vagotomy on response of transplanted pancreas.

Authors:  T E Solomon; M I Grossman
Journal:  Am J Physiol       Date:  1979-02

7.  Some aspects of human and canine macroscopic pancreas innervation.

Authors:  O M Tiscornia; J L Martinez; H Sarles
Journal:  Am J Gastroenterol       Date:  1976-10       Impact factor: 10.864

8.  Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease.

Authors:  J A Chayvialle; F Descos; C Bernard; A Martin; C Barbe; C Partensky
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

9.  Role of the small intestine and gastric antrum in pancreatic polypeptide release.

Authors:  I L Taylor; G L Kauffman; J H Walsh; H Trout; P Chew; J W Harmon
Journal:  Am J Physiol       Date:  1981-05

10.  Immunochemical characterization of gastrinlike and cholecystokininlike peptides released in dogs in response to a peptone meal.

Authors:  M M Wolfe; J E McGuigan
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

View more
  3 in total

Review 1.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

2.  Pancreatic exocrine responses to secretin, 2-deoxyglucose, a meal, and ethanol after coeliac ganglionectomy in the conscious dog.

Authors:  C D Johnson; M A Devaux; H Sarles
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

3.  Vagal-sparing esophagectomy: a more physiologic alternative.

Authors:  Farzaneh Banki; Rodney J Mason; Steven R DeMeester; Jeffrey A Hagen; Nagammapudur S Balaji; Peter F Crookes; Cedric G Bremner; Jeffrey H Peters; Tom R DeMeester
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.